IL27 and metastatic neoplasm: The prevalent inhibition of pro-angiogenic over anti-angiogenic factors is consistent with the poor vascularity of IL30-defective and low metastatic tumors [15] and, by contrast, with the high microvessel density of IL30-overexpressing and rapidly progressing tumors ([16, 17], and data shown in this paper).